ENLV
Enlivex Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.11
−4.31%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.00x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.04x
- Net debt / EBITDA
- 0.10x
Liquidity & coverage
- Current ratio
- 193.24x
- Quick ratio
- 193.24x
- Cash ratio
- 0.65x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $1.7B
Cash & dividend
- FCF / debt
- -17.30x
- Cash flow / debt
- -16.68x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025